Reagents for astatination of biomolecules. 3. comparison of closo-decaborate(2-) and c/oso-dodecaborate(2-) moieties as reactive groups for labeling with astatine-211

Bioconjugate Chemistry

Volumn 20, Issue 3, 2009, Pages 591-602

  Wilbur, D Scott ^a   Chyan, Ming Kuan ^a   Hamlin, Donald K ^a   Perry, Matthew A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; BIOTIN DERIVATIVE; CARBORANE DERIVATIVE; DECABORATE AS 211; DODECABORATE AS 211; IODINE 125; IODINE 131; UNCLASSIFIED DRUG; ASTATINE; BIOTIN; BORON DERIVATIVE; DODECABORATE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CLEARANCE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DISTRIBUTION; HALOGENATION AND DEHALOGENATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; ISOTOPE LABELING; MALE; MOLECULAR STABILITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUDE MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY;

ANIMALS; ASTATINE; BIOTIN; BORON COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; MICE; MICE, NUDE; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 63749103279     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800515d     Document Type: Article

References (45)

1. Couturier, O., Supiot, S., Degraef-Mougin, M., Faivre-Chauvet, A., Carlier, T., Chatal, J. F., Davodeau, F, and Cherel, M. (2005) Cancer radioimmunotherapy with alpha-emitting nuclides. Eur. J. Nucl. Med. Mol. Imaging 32, 601-14.
2. Mulford, D. A., Scheinberg, D. A., and Jurcic, J. G. (2005) The promise of targeted α-particle therapy. J. Nucl. Med. 46, 199S-204S.
3. Zalutsky, M. R. (2006) Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation. J. Nucl. Med. 47, 1238-40.
4. Cherel, M., Davodeau, F., Kraeber-Bodere, F., and Chatal, J. F. (2006) Current status and perspectives in alpha radioimmunotherapy. Q. J. Nucl. Med. Mol. Imaging 50, 322-9.
5. Zalutsky, M. R., Reardon, D. A., Pozzi, O. R., Vaidyanathan, G., and Bigner, D. D. (2007) Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies. Nucl. Med. Biol. 34, 779-85.
6. American Cancer Society. (2008) Cancer Facts and Figures.
7. 211At]astatide and development of labeling reagents to increase stability. Curr. Radiopharm. 1,144-176.
8. Zalutsky, M. R., and Narula, A. S. (1988) Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate. Appl. Radial Isot. 39, 227-232.
9. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem. 3, 433-70.
10. 211 At. Nucl. Med. Biol. 30, 351-359.
11. 211At labeling of proteins. Nucl. Med. Biol. 31, 1061-1071.
12. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Kegley, B. B., Risler, R., Pathare, P. M., Quinn, J., Vessella, R. L., Foulon, C, Zalutsky, M., Wedge, T. J., and Hawthorne, M. F. (2004) Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nWo-carboranyl compounds. Bioconjugate Chem. 15, 203-23.
13. Wilbur, D. S., Chyan, M. K., Hamlin, D. K., Vessella, R. L., Wedge, T. J., and Hawthorne, M. F. (2007) Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Bioconjugate Chem. 18, 1226-40.
14. Tolmachev, V., Koziorowski, J., Sivaev, I., Lundqvist, H., Carlsson, J., Orlova, A., Gedda, L., Olsson, P., Sjoberg, S., and Sundin, A. (1999) Closo-Dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution. Bioconjugate Chem. 10, 338-45.
15. Orlova, A., Lebeda, O., Tolmachev, V., Sjoberg, S., Carlsson, J., and Lundqvist, H. (2000) Closo-dodecaborate (2-) anion as a potential prosthetic group for attachment of astatine to proteins. Aspects of the labelling chemistry with Chloramine-T. J. Labelled Compds. Radiopharm. 43, 251-260.
16. Orlova, A., Lebeda, O., Tolmachev, V., Sjoberg, S., Carlsson, J., and Lundqvist, H. (1999) Astatination of closo-dodecabo- rate(2-) anion. J. Labelled Compd. Radiopharm. 42, S735-S737.
17. -2. Inorg. Chem. 3, 444-451.
18. 2-. J. Am. Chem. Soc. 89, 4842-4850.
19. 2- with oxalyl chloride. Inorg. Chem. 4, 288-293.
20. Gamper, H. B., Reed, M. W., Cox, T., Virosco, J. S., Adams, A. D., Gall, A. A., Scholler, J. K., and Meyer, R. B., Jr. (1993) Facile preparation of nuclease resistant 3′ modified oligodeoxy-nucleotides. Nucleic Acids Res. 21, 145-50.
21. 2. Nucl. Med. Biol. 20, 917-27.
22. Hawthorne, M. F, and Pilling, R. L. (1967) 5. Bis(triethy-lammonium) decahydrodecaborate (2-). Inorg. Synth. 9, 16-19.
23. Miller, H. C, and Muetterties, E. L. (1967) 16. Borane anions. Inorg. Synth. 10, 81-91.
24. 2-. Inorg. Chem. 31, 2889-2892.
25. Kaplan, H. M., Brewer, N. R., and Blair, W. H. (1983) Physiology, In The Mouse in Biomedical Research (Foster, H. L., Small, J. D., and Fox, J. G., Eds.) pp 248-292, Academic Press, New York.
26. Wilbur, D. S., Hamlin, D. K., Chyan, M. K., Kegley, B. B., and Pathare, P. M. (2001) Biotin reagents for antibody pretar-geting. 5. Additional studies of biotin conjugate design to provide biotinidase stability. Bioconjugate Chem. 12, 616-23.
27. 2-. Angew. Chem., Int. Ed. 16, 173-174.
28. -2. Inorg. Chem. 3, 159-167.
29. 2- with an N-fluoro reagent. A new way to transform B-H bonds into B-F bonds. Inorg. Chem. 35, 6914-6915.
30. Wilbur, D. S., Hamlin, D. K., Chyan, M. K., Kegley, B. B., Quinn, J., and Vessella, R. L. (2004) Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives. Bioconjugate Chem. 15, 601-16.
31. 211 (EKA- Iodine) in the thyroid gland of rats and monkeys. J. Clin. Endocrinol. Metab. 14, 1161-1178.
32. Eberle, S. H. (1985) Chemical behavior and compounds of astatine, In Gmelin Handbook of Chemistry, Astatine (Kugler, H. K., and Keller, C, Eds.) pp 183-259, Springer-Verlag, Berlin.
33. Coenen, H. H., Moerlein, S. M., and Stöcklin, G. (1983) No- carrier-added radiohalogenation methods with heavy halogens. Radiochim. Acta 34, 47-68.
34. Kerr, J. A. (1993) Strengths of chemical bonds, In CRC Handbook of Chemistry and Physics (Lide, D. R., Ed.) pp 9-123-9-145, CRC Press, Boca Raton.
35. Wilbur, D. S., Hamlin, D. K., Srivastava, R. R., and Chyan, M. K. (2004) Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives. Nucl. Med. Biol. 31, 523-30.
36. Paxton, R. J., Beatty, B. G., Hawthorne, M. F., Varadarajan, A., Williams, L. E., Curtis, F. L., Knobler, C. B., and Shively, J. E. (1991) A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy. Proc. Nat. Acad. Sci. U.S.A. 88, 3387-3391.
37. 2-. Tetrahedron Lett. 40, 3451-4.
38. -: A new route to water soluble agents for BNCT. Inorg. Chem. 38, 5887-5893.
39. Nestor, M., Persson, M., Cheng, J., Tolmachev, V., Van Dongen, G., Anniko, M., and Kairemo, K. (2003) Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods. Bioconjugate Chem. 14, 805-810.
40. Pispa, J. (1965) Animal biotinidase. Ann. Med. Exptl. Bio. Fenniae 43, 3-40.
41. Chauhan, J., Ebrahim, H., Bhullar, R. P., and Dakshinamurti, K. (1985) Human serum biotinidase. Ann. N.Y. Acad. Sci. 447, 386-388.
42. Hymes, J., Fleischhauer, K., and Wolf, B. (1997) Biotinidase in serum and tissues. Methods Enzymol. 279, 422-434.
43. Wilbur, D. S., Hamlin, D. K., Pathare, P. M., and Weerawama, S. A. (1997) Biotin reagents for antibody pretargeting. Synthesis, radioiodination and in vitro evaluation of water soluble, biotinidase resistant biotin derivatives. Bioconjugate Chem. 8, 572-584.
44. Wilbur, D. S., Hamlin, D. K., and Chyan, M. K. (2006) Biotin reagents for antibody pretargeting. 7. Investigation of chemically inert biotinidase blocking functionalities for synthetic utility. Bioconjugate Chem. 17, 1514-22.
45. Adams, R. (1963) Cage borane nomenclature. Inorg. Chem. 2, 1087-1088.